However, both studies are highly debated [63,64]; a recent study from the Brabletz lab could show that genetic ablation of the EMT-activator ZEB1 in a murine pancreatic cancer model blocks invasion and metastasis, highlighting the non-redundant roles of EMT transcription factors [65,66]. The gene discussed is ZEB1; the disease is pancreatic neoplasm.